KISQALI®
Consumer Medicine Information (CMI) summary
The full CMI on the next page has more details. If you are worried about using this medicine,
speak to your doctor or pharmacist.
Kisqali contains the active ingredient ribociclib (as succinate). Kisqali is used
to treat certain types of breast cancer.
For more information, see Section 1. Why am I using Kisqali? in the full CMI.
Do not use if you have ever had an allergic reaction to ribociclib, cyclin dependent
kinase inhibitors, soy lecithin or any of the ingredients listed at the end of the
CMI. Do not use Kisqali if you have a QT prolongation heart problem.
Talk to your doctor if you have any other medical conditions, take any other medicines,
or are pregnant or plan to become pregnant or are breastfeeding.
For more information, see Section 2. What should I know before I use Kisqali? in the full CMI.
Some medicines may interfere with Kisqali and affect how it works.
A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI.
Kisqali is taken in repeating cycles of 28 days, each day for 21 days followed by
a 7 day treatment break. Kisqali is used in combination with a second medicine (either
an aromatase inhibitor or fulvestrant), which are used as hormonal anticancer therapies.
More instructions can be found in Section 4. How do I use Kisqali? in the full CMI.
|
Things you should do
|
Remind any doctor, dentist or pharmacist you visit that you are using Kisqali.
Keep all your doctor appointments as regular tests on your blood, heart and lung function
are needed.
|
|---|---|
|
Things you should not do
|
Do not take Kisqali if you are pregnant or breastfeeding.
Do not eat grapefruit (or grapefruit juice), pomelo, star fruit or Seville oranges.
|
|
Driving or using machines
|
Treatment with Kisqali may make you feel tired or dizzy.
|
|
Looking after your medicine
|
Store the tablets in a cool dry place below 30°C.
|
For more information, see Section 5. What should I know while using Kisqali? in the full CMI.
There can be serious side effects that need immediate medical attention. These include
allergic reactions, severe skin reactions, infections, liver and heart problems.
For more information, including what to do if you have any side effects, see Section
6. Are there any side effects? in the full CMI.
KISQALI®
Active ingredient:
ribociclib (as succinate)
Consumer Medicine Information (CMI)
This leaflet provides important information about using Kisqali. You should also speak to your doctor or pharmacist if you would like further information
or if you have any concerns or questions about using Kisqali.
Where to find information in this leaflet:
Kisqali contains the active ingredient ribociclib. Kisqali is believed to work by blocking the effects of types of enzymes, called cyclin
dependent kinases (CDK) that chemically signal cancer cells to grow and multiply.
By blocking these enzymes, Kisqali may delay the growth of breast cancer.
Kisqali is used to treat hormone receptor (HR)- positive, human epidermal growth factor
receptor 2 (HER2)- negative breast cancer that is locally advanced or may have also
spread to other parts of the body (metastatic).
Warnings
Do not take Kisqali if:
you are allergic to ribociclib, any cyclin dependent kinase inhibitor, soya lecithin,
or any of the ingredients listed at the end of this leaflet.
Always check the ingredients to make sure you can use this medicine.
you have a heart problem known as QT prolongation.
This is caused by a change in the electrical activity of the heart, and is seen by
your doctor on an ECG (electrocardiogram), or
you have conditions which put you at risk of getting QT prolongation,
such as: a slow heartbeat, low potassium, magnesium, calcium or phosphorous levels in your blood, a family history of QT prolongation, or
such as: a slow heartbeat, low potassium, magnesium, calcium or phosphorous levels in your blood, a family history of QT prolongation, or
you take other medicines which prolong the QT interval.
Women of child-bearing age who recently became postmenopausal or peri menopausal should
not commence treatment with Kisqali until your post-menopausal status is fully established.
Check with your doctor if you:
have any other medical conditions, including:
fever, sore throat or mouth ulcers due to infections (signs of low level of white
blood cells)
problems with your liver or previously had any type of liver disease
heart failure, heart attack, heart disorders or heart rhythm disorders, such as an
irregular heartbeat, including a condition called prolonged QT syndrome (QT interval
prolongation)
low levels of potassium, magnesium, calcium, or phosphorous in your blood
are still having periods
take any other medicines or supplements.
During treatment, you may be at risk of developing certain side effects. It is important
you understand these risks and how to monitor for them. See additional information
under Section 6. Are there any side effects?
Pregnancy and breastfeeding
Check with your doctor if you are pregnant or intend to become pregnant. Kisqali may
harm your unborn baby if you are pregnant. Women who are able to become pregnant should have a negative pregnancy test result
before starting treatment and use effective birth control during treatment and for
at least 21 days after stopping Kisqali.
Talk to your doctor if you are breastfeeding or intend to breastfeed. It is not known
if Kisqali is present in breast milk.
Your doctor will discuss with you the potential risks of taking Kisqali during pregnancy
or when breast feeding.
Tell your doctor or pharmacist if you are taking any other medicines, including any
medicines, vitamins or supplements that you buy without a prescription from your pharmacy,
supermarket or health food shop.
Some medicines may interfere with Kisqali and affect how it works. In particular, these include medicines used to treat:
fungal infections, such as ketoconazole, itraconazole, voriconazole or posaconazole
bacterial infections, such as erythromycin, clarithromycin, azithromycin, moxifloxacin,
levofloxacin, norfloxacin, and ciprofloxacin
HIV/AIDS, such as: ritonavir, saquinavir, idinavir, lopinavir, nelfinavir, telaprevir
and efavirenz
seizures or fits, anti-epileptics such as carbamazepine, phenytoin, rifampin and midazolam
heart rhythm problems, such as amiodarone, disopyramide, procainamide, quinidine and
sotalol
depression, anxiety, sleep problems, or other conditions with a herbal product called
St John's Wort (also known as Hypericum perforatum).
Check with your doctor or pharmacist if you are not sure about what medicines, vitamins
or supplements you are taking and if these affect Kisqali.
Kisqali is taken in repeating cycles of 28 days (4 weeks). It is taken each day for
21 days, followed by a treatment break of 7 days when Kisqali tablets are not taken.
It is taken in combination with a second medicine (either an aromatase inhibitor or
fulvestrant), which are used as hormonal anticancer therapies.
In women who have not reached menopause, and in men, when Kisqali is taken in combination
with an aromatase inhibitor or fulvestrant, a third medicine from the group of luteinising
hormone-releasing hormone (LHRH) agonists should also be taken. LHRH agonists reduce
the amount of oestrogen or testosterone (a hormone) that is produced by your body.
How much to take
Days 1 to 21 (of repeating 28 day cycle)
The usual starting dose is 600 mg (3 x Kisqali 200 mg tablets). Your doctor will tell
you exactly how many tablets to take.
Days 22 to 28 (of repeating 28 day cycle)
Do not take any Kisqali tablets this week.
The 7 day break when you do not take Kisqali tablets will help your body to recover
and decrease the risks of getting any potentially serious side effects or an infection.
If you take Kisqali with an aromatase inhibitor, keep taking the aromatase inhibitor
each day as directed by your doctor.
Start taking Kisqali again the following week on days 1 to 21 as a new 28 day cycle
begins.
When to take Kisqali
Kisqali should be taken at about the same time each day, preferably in the morning
on days 1 to 21 of a 28 day cycle.
Kisqali tablet packs have a fifth flap to help you keep track of your doses during
each treatment cycle. Write in the days of the week starting with the first day of
your treatment. Cross off a circle after each tablet that you take, in each week of
the cycle, as shown in the pack example.
How to take Kisqali
Swallow Kisqali tablets whole with a glass of water or other liquid.
Do not chew, crush or split the tablets prior to swallowing.
Taking Kisqali in combination with an aromatase inhibitor, fulvestrant or LHRH agonist
These medicines are supplied separately. Your doctor will tell you how much and when
to take the aromatase inhibitor or fulvestrant, and LHRH agonist if prescribed.
Keep taking theses medicines as directed by your doctor.
Taking with food or drinks
Kisqali tablets can be taken with or without food.
However,
do not eat grapefruit (or drink grapefruit juice), pomelos, star-fruit, or Seville
oranges during your treatment with Kisqali. These foods may change the way Kisqali is absorbed into your body.
How long to keep taking Kisqali
This is a long-term treatment, which may continue for many months or years.
Continue taking Kisqali once a day on days 1 to 21, of repeating 28 day cycles, for
as long as your doctor tells you to. Your doctor will regularly check your condition to ensure that Kisqali treatment is
having the desired effect on you.
If you forget to use Kisqali
Kisqali should be taken regularly at the same time each day on days 1 to 21.
If you miss a dose during days 1 to 21, skip the missed dose and take your next dose
at your regular time on the next day.
Do not take a double dose to make up for the dose you missed.
If you have trouble remembering when to take or skip Kisqali, keep a treatment diary,
or ask your doctor, nurse or pharmacist for some hints.
If you take too much Kisqali
If you think that you have taken too much Kisqali, you may need urgent medical attention.
You should immediately:
phone the Poisons Information Centre (by calling 13 11 26), or
contact your doctor, or
go to the Emergency Department at your nearest hospital.
You should do this even if there are no signs of discomfort or poisoning.
Things you should do
Follow your doctor’s instructions carefully. Your treatment may not help or you may have unwanted side effects if you do not follow
the instructions.
Keep all your doctor’s appointments to check your progress:
You will have regular blood tests before and during treatment with Kisqali to monitor
how your liver is working, the amount of blood cells, and electrolytes (blood salts
including potassium, calcium, magnesium and phosphate) in your body.
The electrical activity of your heart will be checked before and during treatment
(with a test called an electrocardiogram or ECG). These test results can change when
taking Kisqali.
Your lung function will be checked.
If necessary, additional tests to check how your kidneys are working will be done.
If necessary, your doctor may decide to stop Kisqali for a short time or reduce your
Kisqali dose to allow your liver, kidneys, blood cells, electrolytes, lungs or heart
activity to recover. Your doctor may also decide to stop treatment permanently.
Call your doctor straight away if you:
Become pregnant – you should not take this medicine while you are pregnant.
Remind any doctor, dentist or pharmacist you visit that you are using Kisqali.
Things you should not do
If you take Kisqali with an aromatase inhibitor, do not skip the aromatase inhibitor
on any day. It must be taken every day as directed in the 28 day cycle
Do not use Kisqali to treat any other complaint unless your doctor says you can
Do not give this medicine to anyone else.
Driving or using machines
Be careful before you drive or use any machines or tools until you know how Kisqali
affects you.
Kisqali may cause tiredness, dizziness or vertigo in some people.
Looking after your medicine
Follow the instructions in the carton on how to take care of your medicine properly.
Store it in a cool dry place below 30°C, away from moisture, heat or sunlight; for
example, do not store it:
in the bathroom or near a sink, or
in the car or on window sills.
Keep it where young children cannot reach it.
Getting rid of any unwanted medicine
If you no longer need to use this medicine or it is out of date, take it to any pharmacy
for safe disposal.
Do not use this medicine after the expiry date.
All medicines can have side effects. If you do experience any side effects, most of
them are minor and temporary. However, some side effects may need medical attention.
See the information below and, if you need to, ask your doctor or pharmacist if you
have any further questions about side effects.
Very common side effects
|
Very common side effects
|
What to do
|
|---|---|
|
Tiredness, fatigue, pale skin, feeling weak
Respiratory tract problems
Sore throat
Runny nose, blocked nose
Sneezing
Feeling of pressure or pain in the cheeks or forehead with or without fever,
Cough, hoarseness, weak voice or voice loss
Mouth, stomach or bowel problems
Reduced appetite
Nausea, vomiting
Diarrhea, constipation
Mouth sores or ulcers with gum inflammation
Stomach pain
Painful and frequent urination
Back pain
Hair loss or thinning
Rash, itching
Headache
Swollen hands, ankles or feet
Dizziness or lightheadedness
|
Speak to your doctor if you have any of these very common side effects and they worry
you.
|
Common side effects
|
Common side effects
|
What to do
|
|---|---|
|
Mouth, stomach or bowel problems
Abdominal pain, nausea, vomiting, diarrhoea, swelling or bloating of the abdomen and
feeling sick
Strange taste in the mouth, dry mouth
Sore throat
Upset stomach, indigestion, heartburn
Watering or tearing of the eyes, dry eye
Skin reddening
Loss of skin colour in patches
Dry skin.
|
Speak to your doctor if you have any of these common side effects and they worry you.
|
Serious side effects
|
Serious side effects
|
What to do
|
|---|---|
|
Allergic reactions
severe itching of the skin, with a red rash, or raised bumps;
swelling of the face, lips, tongue, throat, or other parts of the body;
difficulty in breathing or swallowing
dizziness.
Infections showing signs of:
fever, sweats or chills, cough, flu like symptoms, weight loss, shortness of breath,
blood in your phlegm, sores on your body, warm or painful areas on your body, diarrhoea
or stomach pain, feeling very tired
fever, sore throat or mouth ulcers
increased heart rate, shortness of breath or rapid breathing, fever and chills (these
may be signs of a sepsis which is an infection in the blood system which may be life
threatening)
Heart problems
chest pain or discomfort
changes in heart beat (fast, slow or irregular), palpitations,
light headedness, fainting, dizziness
lips turning blue colour
shortness of breath
swelling (oedema) of your lower limbs or skin.
Severe skin reactions:
blistering peeling skin with painful raw areas, fever, flu-like symptoms
rash, blisters or lesions.
Signs of liver problems
tiredness
itchy yellow skin or yellowing of the whites of your eyes
nausea or vomiting, loss of appetite
pain in the upper right side of the belly (abdomen)
dark or brown urine
bleeding or bruising more easily than normal.
Other serious side effects:
sore throat or mouth ulcers with a single episode of fever greater than 38.3°C, or
above 38°C for more than one hour and/or with infection
shortness of breath, cough, anxiety, confusion and restlessness.
|
Stop taking Kisqali and call your doctor straight away, or go straight to the Emergency
Department at your nearest hospital if you notice any of these serious side effects.
|
Tell your doctor or pharmacist if you notice anything else that may be making you
feel unwell.
Other side effects not listed here may occur in some people.
Some side effects can only be found when your doctor does tests to check your progress.
It is very common for Kisqali to affect certain blood and liver function tests, and
common for Kisqali to affect heart test results.
Your doctor will discuss with you what to do if any of your test results are affected.
Reporting side effects
After you have received medical advice for any side effects you experience, you can
report side effects to the Therapeutic Goods Administration online at www.tga.gov.au/reporting-problems . By reporting side effects, you can help provide more information on the safety of
this medicine.
Always make sure you speak to your doctor or pharmacist before you decide to stop
taking any of your medicines.
This medicine is only available with a doctor's prescription.
What Kisqali contains
|
Active ingredient
(main ingredient)
|
Each tablet contains 200 mg ribociclib, as the succinate salt.
|
|---|---|
|
Other ingredients
(inactive ingredients)
|
Magnesium stearate (vegetable source) (E572)
Microcrystalline cellulose (E460(i))
Hyprolose (E463)
Crospovidone (E1202)
Colloidal silicon dioxide
Polyvinyl alcohol (partially hydrolysed) (E1203)
Titanium dioxide (E171)
Iron oxide black CI77499 (E172)
Iron oxide red CI77491 (E172)
Iron oxide yellow CI77492 (E172)
Purified talc (E553b)
Lecithin (soy) (E322)
Xanthan gum (E415).
|
|
Potential allergens
|
Soy lecithin
|
Do not take this medicine if you are allergic to any of these ingredients.
Kisqali does not contain sucrose, lactose, gluten, tartrazine, azo dyes, or any animal
products.
What Kisqali looks like
Kisqali film coated tablets are light greyish violet, unscored, round, curved with
bevelled edges, debossed with "RIC" on one side and "NVR" on the other side (Aust
R 280246).
The tablets are supplied in packs containing either 63, 42, or 21 tablets. All packs
contain three blister strips in each carton.
63 tablets: this pack is for patients taking 600 mg (as three 200 mg tablets) ribociclib
once each day for 3 weeks. Each blister strip contains 21 tablets.
42 tablets: this pack is for patients taking 400 mg (as two 200 mg tablets) ribociclib
once each day for 3 weeks. Each blister strip contains 14 tablets.
21 tablets: this pack is for patients taking the lowest ribociclib daily dose of 200
mg (one tablet) once each day. Each blister strip contains 7 tablets.
Who distributes Kisqali
Novartis Pharmaceuticals Australia Pty Limited
(ABN 18 004 244 160)
54 Waterloo Road
Macquarie Park NSW 2113
Telephone 1 800 671 203
Website: www.novartis.com.au
® = Registered trademark
© Copyright 2023
This leaflet was prepared in March 2023.
Internal document code
(kis270323c is based on PI kis270323i).
